The Supreme Court has temporarily extended women’s access to an abortion pill until Friday while the justices consider whether to allow restrictions on mifepristone to take effect as a legal challenge to the medication’s FDA approval continues.
In an order signed by Justice Samuel Alito on Wednesday, the court indicated it will act by Friday night.
The drug first won FDA approval in 2000, and conditions on its use have been loosened in recent years, including making it available by mail in states that allow access.
The Biden administration and New York-based Danco Laboratories, the maker of the drug, want the nation’s highest court to reject limits on mifepristone’s use imposed by lower courts, at least as long as the legal case makes it way through the courts. They say women who want the drug and providers who dispense it will face chaos if limits on the drug take effect. Depending on what the justices decide, that could include requiring women to take a higher dosage of the drug than the FDA says is necessary.
Read this story for free
To continue reading, sign up for our newsletters and get unlimited access to WABE.org
We won't share your information with outside organizations Why am I seeing this?
